"MedStar Good Samaritan Hospital is an adult care community hospital with a rich Catholic heritage, serving the communities of northeast Baltimore. Our specialized programs include cancer care, geriatric care, behavioral and mental health, and rehabilitation services. Our cancer center provides screening, diagnosis, and treatment for breast cancer, lung cancer, and colorectal cancer patients. At the Center for Successful Aging, you and your loved ones have access to a team of physicians that work together to coordinate your care, from primary care visits, to treatment of dementia or movement disorders. Our inpatient rehabilitation experts are here for you after a stroke, brain injury, or spinal cord injury."

During the past decade, MedStar Good Samaritan Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 9 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MedStar Good Samaritan Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 9 trials, followed by "National Cancer Institute (NCI)" with 7 trials sponsored, "NRG Oncology" with 4 trials sponsored, "Georgetown University" with 2 trials sponsored and "Medstar Health Research Institute" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MedStar Good Samaritan Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "MedStar Good Samaritan Hospital" are "Breast Adenocarcinoma" (4 trials), "Breast Cancer" (4 trials), "Invasive Breast Carcinoma" (4 trials), "Stage IIIA Breast Cancer" (3 trials) and "Anatomic Stage IA Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "MedStar Good Samaritan Hospital" in a lesser frequency.

Most popular intervention types in "MedStar Good Samaritan Hospital" are "Drug" (25 trials), "Other" (21 trials), "Radiation" (7 trials), "Biological" (6 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (8 trials), "Laboratory Biomarker Analysis" (7 trials), "Questionnaire Administration" (4 trials), "Paclitaxel" (3 trials) and "Anastrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "MedStar Good Samaritan Hospital" are 27 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MedStar Good Samaritan Hospital". undefined are not yet recruiting, 11 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in MedStar Good Samaritan Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MedStar Good Samaritan Hospital, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".